America in Transition Pages

Tuesday, March 29, 2016

Gliptin Game May Get More Crowded in 2016

(MedPage Today) -- Merck's DPP-4 inhibitor omarigliptin under FDA review

from MedPage Today Washington Watch http://ift.tt/1RIto5f
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)